Is a complete KURA research report available?

No complete published report is available for Kura Oncology, Inc. (KURA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Kura Oncology, Inc. (KURA)

NASDAQ: KURA · USD

$9.31

+0.38 (+4.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first KURA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	826.5M
Revenue (ttm)	71.6M
Net income (ttm)	-294.6M
EPS (ttm)	-$3.35
Shares out	88.8M
Volume	1,408,540
Beta	0.35
Price target	$31.2	+234.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 71.6M
Net income (ttm): -294.6M
EPS (ttm): -$3.35
Market cap: 826.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All KURA indicators

Market & fundamental data

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001422143
Company name	Kura Oncology, Inc.
Country	United States
Country code	US
Cusip	50127T109
Employees	260
Employees Change	68%
Employees Change Percent	35.42
Enterprise value	$269.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US50127T1097
Last refreshed	2026-07-31
Market cap	$826.5M
Market cap category	Small-Cap
Price	$9.31
Price currency	USD
Rev Per Employee	275,534.62x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	KURA
Website	https://kuraoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-35.64%
EV Sales Forward	2.31x
EV/Sales	3.77x
FCF yield	-10.22%
P/B ratio	7.66x
P/S ratio	11.54x
PS Forward	7.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-510.39%
EBITDA Margin	-508.59%
Gross margin	-263.88%
Gross Profit	$-189M
Net Income	$-294.6M
Net Income Growth Years	0%
Pretax Margin	-411.08%
Profit Per Employee	$-1.1M
ROA	-28.45
Roa5y	-19.95
ROCE	-59.04
ROE	-124.7
Roe5y	-45.55
ROIC	-76.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.53%
Cagr1y	46.19%
Cagr3y	-2.26%
Cagr5y	-13.31%
EPS Growth Years	0
Revenue Growth	5.37x
Revenue Growth Q	29.47x
Revenue Growth Quarters	1x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.1
Assets	$652.6M
Cash	$580.8M
Current Assets	$623.8M
Current Liabilities	$101.5M
Debt	$24.3M
Debt Equity	$0.22
Equity	$107.9M
Interest Coverage	-221.9
Liabilities	$544.7M
Long Term Assets	$28.8M
Long Term Liabilities	$443.2M
Net Cash	$556.6M
Net Cash By Market Cap	$67.34
Net Cash Growth	-12.88%
Net Debt Equity	$-5.16
Tangible Book Value	$107.9M
Tangible Book Value Per Share	$1.22
WACC	6.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.15
Net Working Capital	$-57.3M
Quick ratio	5.86
Working Capital	$522.3M
Working Capital Turnover	$0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	126.63%
1Y total return	46.15%
200-day SMA	9.65
3Y total return	-6.62%
50-day SMA	10.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-51.03%
All Time High	43
All Time High Change	-78.35%
All Time High Date	2020-12-09
All Time Low	2.5
All Time Low Change	272.4%
All Time Low Date	2016-07-05
ATR	0.54
Beta	0.35
Beta1y	1.52
Beta2y	1.42
Ch YTD	-10.39
High	9.38
High52	12.49
High52 Date	2025-11-14
High52ch	-25.46%
Low	8.9
Low52	5.45
Low52 Date	2025-08-11
Low52ch	70.83%
Ma50ch	-8.73%
Premarket Change Percent	0.67
Premarket Price	$8.99
Price vs 200-day SMA	-3.5%
RSI	36.89
RSI Monthly	46.22
RSI Weekly	48.53
Sharpe ratio	0.86x
Sortino ratio	1.49
Total Return	-1.08%
Tr YTD	-10.39
Tr1m	-15.13%
Tr1w	-10.91%
Tr3m	6.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	6
Analyst Price Target Top	$28.2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.89
Earnings Revenue Estimate	19,521,976x
Earnings Revenue Estimate Growth	27.69x
Operating Income	$-317.7M
Operating margin	-443.5
Price target	$31.17
Price Target Change	$235
Price Target Change Top	$203

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	70,415,959%
Float Percent	79.32%
Shares Insiders	1.51%
Shares Institutions	77.71%
Shares Out	88,774,365
Shares Qo Q	0.64%
Shares Yo Y	1.08%
Short Float	19.5%
Short Ratio	7.67
Short Shares	15.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-122.1M
Adjusted OCF	-115,667,000
Average Volume	1,419,609.6x
Bv Per Share	1.22
CAPEX	$-6.5M
Ch10y	126.6
Ch1m	-15.13
Ch1w	-10.91
Ch1y	46.15
Ch3m	6.4
Ch3y	-6.62
Ch5y	-51.03
Ch6m	13.26
Change	4.26%
Change From Open	4.14
Close	8.93
Days Gap	0.11
Depreciation Amortization	1,146,000
Dollar Volume	13,113,507.4
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-325.3M
EBITDA	$-324.2M
EPS	$-3.35
F Score	1
FCF	$-84.5M
FCF EV Yield	-31.29x
FCF Per Share	$-0.95
Financing CF	1,719,000
Fiscal Year End	December
Founded	2,014
Income Tax	$79,000
Investing CF	64,080,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	9.33
Ma150ch	-0.17%
Ma20	10.78
Ma20ch	-13.66%
Net CF	-12,186,000
Next Earnings Date	2026-08-10
Open	8.94
Optionable	Yes
Position In Range	85.42
Post Close	9.31
Postmarket Change Percent	0.54
Postmarket Price	$9.36
Ppne	14,779,000
Pre Close	8.93
Price Date	2026-07-30
Ptbv Ratio	7.66
Relative Volume	0.99x
Revenue	71,639,000x
SBC By Revenue	52.6x
Share Based Comp	37,682,000
Tax By Revenue	0.11x
Tr6m	13.26%
Us State	California
Volume	1,408,540
Z Score	-2.44

Kura Oncology, Inc. (KURA)

Coverage state: Market snapshot only — no published research

Generate the first KURA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · KURA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KURA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on KURA

Frequently asked questions